Effects of a 12-week cardiovascular rehabilitation programme on systemic inflammation and traditional coronary artery disease risk factors in patients with rheumatoid arthritis (CARDIA trial): a randomised controlled trial

Stefan Heinze-Milne, Volodko Bakowsky, Nicholas Giacomantonio, Scott A Grandy, Stefan Heinze-Milne, Volodko Bakowsky, Nicholas Giacomantonio, Scott A Grandy

Abstract

Introduction: Patients with systemic inflammatory diseases such as rheumatoid arthritis (RA) have an increased risk of cardiovascular disease (CVD) above the baseline risk attributable to traditional CVD risk factors seen in the general population. Exercise in cardiac rehabilitation (CR) is designed specifically for high-risk primary prevention and those with established CVD. Even though the European League Against Rheumatism guidelines state that exercise is safe for individuals with RA and exercise can reduce CVD risk, patients with RA rarely participate in CR. Thus, little is known about CR's impact on inflammatory and CVD risk in the RA population. The purpose of this trial is to determine the feasibility of a 12-week CR programme for patients with RA and whether it decreases CVD risk without exacerbating RA.

Methods and analysis: This is a randomised controlled trial whereby 60 participants with RA will be recruited and randomly assigned to either standard of care (SOC) treatment or SOC plus a 12-week CR programme (60 min of education plus two 60 min aerobic exercise sessions/week). Exercise will be performed at 60%-80% of heart rate reserve. Outcome measures (Framingham Risk Score, resting heart rate, blood pressure, blood lipids, markers of systemic inflammation (ie, interleukin (IL) 6 and tumour necrosis factor-α (TNF-α), Clinical Disease Assessment Index, Disease Activity Score-28, physical activity levels and peak cardiorespiratory fitness) will be assessed preintervention (week-0), postintervention (week-13) and 6 months postintervention.

Ethics and dissemination: Ethical approval was obtained from the Nova Scotia Health Authority Research Ethics Board. Results will be submitted for publication in an appropriate peer-reviewed journal.

Trial registration number: NCT01534871; Pre-results.

Keywords: cardiovascular disease; exercise; inflammation; rehabilitation medicine; rehumatoid arthritis.

Conflict of interest statement

Competing interests: None declared.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

References

    1. Aletaha D, Neogi T, Silman AJ, et al. . 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569–81. 10.1002/art.27584
    1. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008;26:S35–61.
    1. Kaplan MJ. Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment. Rheum Dis Clin North Am 2010;36:405–26. 10.1016/j.rdc.2010.02.002
    1. Goodson N. Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol 2002;14:115–20. 10.1097/00002281-200203000-00007
    1. Chung CP, Oeser A, Raggi P, et al. . Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 2005;52:3045–53. 10.1002/art.21288
    1. Erb N, Pace AV, Douglas KM, et al. . Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2004;33:293–9. 10.1080/03009740410006899
    1. del Rincón ID, Williams K, Stern MP, et al. . High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737–45. 10.1002/1529-0131(200112)44:12<2737::AID-ART460>;2-#
    1. Rho YH, Chung CP, Oeser A, et al. . Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2009;61:1580–5. 10.1002/art.25009
    1. Kozera L, Andrews J, Morgan AW. Cardiovascular risk and rheumatoid arthritis–the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation. Rheumatology 2011;50:1944–54. 10.1093/rheumatology/ker232
    1. Sattar N, McCarey DW, Capell H, et al. . Explaining how ‘high-grade’ systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957–63. 10.1161/01.CIR.0000099844.31524.05
    1. Skeoch S, Bruce IN. Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol 2015;11:390–400. 10.1038/nrrheum.2015.40
    1. Mahmoudi M, Aslani S, Fadaei R, et al. . New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis. Int J Rheum Dis 2017;20:287–97. 10.1111/1756-185X.12999
    1. Metsios GS, Koutedakis Y, Veldhuijzen van Zanten JJ, et al. . Cardiorespiratory fitness levels and their association with cardiovascular profile in patients with rheumatoid arthritis: a cross-sectional study. Rheumatology 2015;54:kev035–20. 10.1093/rheumatology/kev035
    1. Tremblay MS, Warburton DE, Janssen I, et al. . New Canadian physical activity guidelines. Appl Physiol Nutr Metab 2011;36:36–46. 10.1139/H11-009
    1. Handschin C, Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008;454:463–9. 10.1038/nature07206
    1. Lavie CJ, Church TS, Milani RV, et al. . Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev 2011;31:137–45. 10.1097/HCR.0b013e3182122827
    1. Kim YJ, Shin YO, Bae JS, et al. . Beneficial effects of cardiac rehabilitation and exercise after percutaneous coronary intervention on hsCRP and inflammatory cytokines in CAD patients. Pflugers Arch 2008;455:1081–8. 10.1007/s00424-007-0356-6
    1. Kodama S, Saito K, Tanaka S, et al. . Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 2009;301:2024–35. 10.1001/jama.2009.681
    1. Piepoli MF, Corrà U, Adamopoulos S, et al. . Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: A policy statement from the cardiac rehabilitation section of the european association for cardiovascular prevention & rehabilitation. Endorsed by the committee for practice guidelines of the european society of cardiology. Eur J Prev Cardiol 2014;21:664–81. 10.1177/2047487312449597
    1. Redberg RF, Benjamin EJ, Bittner V, et al. . AHA/ACCF 2009 performance measures for primary prevention of cardiovascular disease in adults. Circulation 2009;120:1296–336.
    1. Taylor RS, Brown A, Ebrahim S, et al. . Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004;116:682–92. 10.1016/j.amjmed.2004.01.009
    1. Agca R, Heslinga SC, Rollefstad S, et al. . EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 2017;76:17–28. 10.1136/annrheumdis-2016-209775
    1. Metsios GS, Stavropoulos-Kalinoglou A, Veldhuijzen van Zanten JJ, et al. . Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. Rheumatology 2008;47:239–48. 10.1093/rheumatology/kem260
    1. Douglas KM, Pace AV, Treharne GJ, et al. . Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann Rheum Dis 2006;65:348–53. 10.1136/ard.2005.037978
    1. Ehrlich-Jones L, Lee J, Semanik P, et al. . Relationship between beliefs, motivation, and worries about physical activity and physical activity participation in persons with rheumatoid arthritis. Arthritis Care Res 2011;63:1700–5. 10.1002/acr.20616
    1. de Jong Z, Munneke M, Zwinderman AH, et al. . Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial. Arthritis Rheum 2003;48:2415–24. 10.1002/art.11216
    1. Plasqui G. The role of physical activity in rheumatoid arthritis. Physiol Behav 2008;94:270–5. 10.1016/j.physbeh.2007.12.012
    1. Metsios GS, Stavropoulos-Kalinoglou A, Sandoo A, et al. . Vascular function and inflammation in rheumatoid arthritis: the role of physical activity. Open Cardiovasc Med J 2010;4:89–96. 10.2174/1874192401004010089
    1. Stenström CH, Minor MA. Evidence for the benefit of aerobic and strengthening exercise in rheumatoid arthritis. Arthritis Rheum 2003;49:428–34. 10.1002/art.11051
    1. Robustillo Villarino M, Rodilla Sala E, Gil Latorre F, et al. . AB0372 Physical Exercise has no Influence on Markers of Subclinical Cardiovascular Disease in Patients with Rheumatoid Arthritis. Ann Rheum Dis 2015;74(Suppl 2):1018.1–1018. 10.1136/annrheumdis-2015-eular.3132
    1. Stavropoulos-Kalinoglou A, Metsios GS, Veldhuijzen van Zanten JJ, et al. . Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis. Ann Rheum Dis 2013;72:1819–25. 10.1136/annrheumdis-2012-202075
    1. Cersit HP, Yagci I, Cersit S, et al. . Sat0112 the effect of cardiac rehabilitation program on disease activity, functional outcome and cardiovascular risk in patients with rheumatoid arthritis. Ann Rheum Dis 2016;75(Suppl 2):705–6.
    1. Shaw I, Shaw BS, Brown GA, et al. . Concurrent resistance and aerobic training as protection against heart disease. Cardiovasc J Afr 2010;21:196–9.
    1. Committee IR. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)–short and long forms, 2005.
    1. Medicine ACoS. ACSM’s guidelines for exercise testing and prescription. USA: Lippincott Williams & Wilkins, 2013.
    1. Dickens C, McGowan L, Clark-Carter D, et al. . Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002;64:52–60. 10.1097/00006842-200201000-00008
    1. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24–31. 10.1016/j.it.2005.11.006
    1. Wilson PW, D’Agostino RB, Levy D, et al. . Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837–47. 10.1161/01.CIR.97.18.1837
    1. Anderson TJ, Grégoire J, Hegele RA, et al. . 2012 update of the canadian cardiovascular society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 2013;29:151–67. 10.1016/j.cjca.2012.11.032
    1. Bard RL, Rubenfire M, Eagle K, et al. . Utility of C-reactive protein measurement in risk stratification during primary cardiovascular disease prevention. Am J Cardiol 2005;95:1378–9. 10.1016/j.amjcard.2005.01.089
    1. Felson DT, Anderson JJ, Boers M, et al. . The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis & Rheumatism 1993;36:729–40. 10.1002/art.1780360601
    1. Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 1973;85:546–62. 10.1016/0002-8703(73)90502-4
    1. Lerman J, Bruce RA, Sivarajan E, et al. . Low-level dynamic exercises for earlier cardiac rehabilitation: aerobic and hemodynamic responses. Arch Phys Med Rehabil 1976;57:355–60.
    1. Gibbons RJ, Balady GJ, Bricker JT, et al. . Acc/aha 2002 guideline update for exercise testing: Summary article. A report of the american college of cardiology/american heart association task force on practice guidelines (committee to update the 1997 exercise testing guidelines). J Am Coll Cardiol 2002;40:1531–40.
    1. Foster C, Jackson AS, Pollock ML, et al. . Generalized equations for predicting functional capacity from treadmill performance. Am Heart J 1984;107:1229–34. 10.1016/0002-8703(84)90282-5
    1. Pollock ML, Foster C, Schmidt D, et al. . Comparative analysis of physiologic responses to three different maximal graded exercise test protocols in healthy women. Am Heart J 1982;103:363–73. 10.1016/0002-8703(82)90275-7
    1. Craig CL, Marshall AL, Sjöström M, et al. . International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381–95. 10.1249/01.MSS.0000078924.61453.FB
    1. Metsios GS, Stavropoulos-Kalinoglou A, Treharne GJ, et al. . Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis. Arthritis Res Ther 2011;13:R108 10.1186/ar3390
    1. Demmelmaier I, Bergman P, Nordgren B, et al. . Current and maintained health-enhancing physical activity in rheumatoid arthritis: a cross-sectional study. Arthritis Care Res 2013;65:1166–76. 10.1002/acr.21951
    1. Hernández-Hernández V, Ferraz-Amaro I, Díaz-González F. Influence of disease activity on the physical activity of rheumatoid arthritis patients. Rheumatology 2014;53:722–31. 10.1093/rheumatology/ket422
    1. Fries JF, Spitz P, Kraines RG, et al. . Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137–45. 10.1002/art.1780230202
    1. Bruce B, Fries JF. The stanford health assessment questionnaire: Dimensions and practical applications. Health Qual Life Outcomes 2003;1:20 10.1186/1477-7525-1-20
    1. Bruce B, Fries JF. The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol 2005;23:S14.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться